TW201036621A - Suspension liquid of Ganoderma lucidum fruiting bodies and nano/submicron scale suspension liquid of Ganoderma lucidum fruiting bodies - Google Patents

Suspension liquid of Ganoderma lucidum fruiting bodies and nano/submicron scale suspension liquid of Ganoderma lucidum fruiting bodies Download PDF

Info

Publication number
TW201036621A
TW201036621A TW98111670A TW98111670A TW201036621A TW 201036621 A TW201036621 A TW 201036621A TW 98111670 A TW98111670 A TW 98111670A TW 98111670 A TW98111670 A TW 98111670A TW 201036621 A TW201036621 A TW 201036621A
Authority
TW
Taiwan
Prior art keywords
ganoderma lucidum
suspension
fruit body
particles
particle size
Prior art date
Application number
TW98111670A
Other languages
Chinese (zh)
Other versions
TWI377065B (en
Inventor
yi-xian Jiang
Ying-Sheng Lin
An-Yi Ye
yu-xiu Zheng
Ya-Yi Huang
Jun-Zhou Lin
Shang-Lin Wu
Wei-Huang Gao
Original Assignee
Sheng Chun Tang Pharmaceutical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sheng Chun Tang Pharmaceutical Ind Co Ltd filed Critical Sheng Chun Tang Pharmaceutical Ind Co Ltd
Priority to TW98111670A priority Critical patent/TW201036621A/en
Publication of TW201036621A publication Critical patent/TW201036621A/en
Application granted granted Critical
Publication of TWI377065B publication Critical patent/TWI377065B/zh

Links

Abstract

Disclosed are suspension liquid of Ganoderma lucidum fruiting bodies and nano/submicron scale suspension liquid of Ganoderma lucidum fruiting bodies, wherein the suspension liquid of Ganoderma lucidum fruiting bodies is the liquid containing Ganoderma lucidum particles obtained by mechanical grinding of Ganoderma lucidum fruiting bodies, which also contains fiber, chitin, and β -glucan. The average particle diameter of Ganoderma lucidum particles is less than 10 μ m. Such suspension liquid of Ganoderma lucidum fruiting bodies made by mechanical grinding is characterized in that the complete active ingredients can be obtained without any extraction operation. In addition, fiber surface area can be substantially increased, no further grinding operations are needed in the subsequent use of fiber, and can be used as a good meal fiber additives.

Description

201036621 六、發明說明: 【發明所屬之技術領域】 本發明是有關於一種靈芝液, 收将別疋指一種經由機赫 式研磨製成之靈芝子實體懸浮液。 ^ 【先前技術】 Ο 奈米/次微米產品是近年來的熱門話題,近年來 研究學者、業者與-般大眾的注意,有鐘於奈米/次微 技的重要性及潛力,很多國家已將奈米/次微米科技之相關 研究列為優先考量,且-但將奈米/次微米科技應用於食品 材料上,將對全球的食品系統造成革命性的改變,雖然目 前奈米/次微米食品材料的研究尚屬於起步階段,但食材粒 子細小後,應可提高吸收率,而有助於嬰兒、老人或消化 系統不良者攝取必須的營養物質,且可應用於中草藥 藥效更容易發揮,為達到這此县士认ημ Α ' j w二長遠的目標,食品材料的奈 米/次微米化技術與產品性質的瞭解是一項重要的課題。、 於中草藥中,靈芝子實體 貝體被公涊為具有多項保健功能 ’如抗腫瘤、調節免疫機能、限丄nt 機舱降血脂、降血壓、降血糖、 抗病毒、抗過敏、抗氧化、抗輕射、抑制血小板凝隼與止 痛等,無論是以完整子實體或萃取物食用,靈^實Μ 當安全的中草藥,甚至給予高劑量,例如:每曰%^之乾 燥子實體萃取物,經證實亦無顯著的毒性反應,且利用動 物實驗評估靈芝的營養價值和毒性,結果顯示靈芝並無基 因毒性(genotoxicity)。 據估計’ 2001年全世界靈芝的產量為棚嘲,中國大 3 201036621 陸是最大生產國( 3500噸),約有200萬人食用靈芝,即每 人每年約消耗2·5公斤,消費者健康意識的增加,使靈芝產 品市場將逐年成長。但市面上的靈芝產品很多種,常見的 為:整株靈芝、靈芝切片、膠囊、顆粒、錠丸與液狀飲品 (靈芝茶、靈芝酒、靈芝糖漿及靈芝飲料)等,依其有效 成份含量而言,品質優劣參差不齊。雖然靈芝保健食品是 目前食品市場的熱門商品,然而,其有效成分(例如幾丁 質、募醣、β-葡聚糖)萃取不易、溶解度低,於人體内的吸 收亦不甚理想,且萃取後之靈芝渣(多為膳食纖維之成分 )又常被視為廢棄物,而造成資源的浪費。 經申請人研究,若能將完整之靈芝子實體粒徑奈米/次 微米化處理,製成奈米/次微米級靈芝子實體懸浮液,不但 t助於靈芝多醣等活性成分的釋出,而獲得完整的活性成 分,及增加活性成分的吸收與利用外,還可從中獲得奈米/ 次微米化之膳食纖維,而同時減少廢棄物的產生。 【發明内容】 ,因此,本發明之目的,即在提供一種經由機械式研磨 製成,且具有細小靈芝微粒的靈芝子實體懸浮液。 本發明之另一目的,即在提供一種經由機械式研磨製 成,且具有奈米/次微米、級靈芝微粒的靈芝子實體懸浮液。 於是,本發明靈芝子實體懸浮液,為靈芝子實體經由 機械式研磨後所得到含有靈芝微粒之靈芝子實體懸浮液, 並含有纖維質、幾丁質,及β_葡聚糖,且靈芝微粒之體積 平均粒徑小於10 μιη。 201036621 於是,本發明奈米/次微米級靈芝子實體懸浮液,是將 靈芝子實體經由機械式研磨後所得到含有靈芝微粒之靈芝 子實體懸浮液,再經離心所得到之離心上清液,該奈米/次 微米級靈芝子實體懸浮液含有纖維質、幾丁質,及卜葡聚 糖,且靈芝微粒之體積平均粒徑小於 2 μπι。 本發明之功效:透過機械式研磨來製造靈芝子實體懸 洋液的方式,除了無須萃取即可獲得完整的活性成分外, 還可大幅提高纖維質比表面積,且纖維質之後續利用無須 再粉碎,可作為一良好的膳食纖維添加物。 【實施方式】 有關本發明之前述及其他技術内容、特點與功效,在 以下配合參考圖式之一個較佳實施例的詳細說明中,將可 清楚的呈現。 本發明靈芝子實體懸浮液的較佳實施例,係由整株靈 芝子實體經過機械式研磨處理製成,該靈芝子實體懸浮液 包含經由機械式研磨靈芝子實體所得到之靈芝微粒,及與 靈之子實體一起進行研磨之可食性乳化劑。 機械式奈米研磨乃是利用機械能量、研磨介質(研磨 珠)間的碰撞作用’以及漿料_流體與流體研磨珠間的劈切 力,將大粒子破碎與分散,常用於塗料或奈米粉體製備。 機械式研磨機配有冷卻系統,可避免高溫的產生,有利於 對熱敏感之有機材料的處理,例如食品材料與中草藥等。 以下即以傳統熱水萃取法獲得之萃取物,與本發明直 接將靈芝子實體以機械式研磨進行奈米/次微米化處理後之 5 201036621 靈芝子實體懸浮液進行比較說明。 對照組:傳統熱水萃取 將靈芝子實體清洗後置於7(TC烘箱中,以熱風乾燥至 水份殘餘約10%左右。利用粉碎機(RT-04, Rong Tsong Iron Co., Taiwan)細碎成粉末備用。取300 g靈芝子實體粉末加 入4500 mL蒸傭水,於100°C加熱2小時,趁熱以60 mesh 篩網先行粗慮,所得遽液再以 Whatman No.4濾、紙( Whatman, Springfield Mill, UK)過濾以除去細微殘潰,可 得黃色濾液,即為萃取液。殘渣再加入4500 mL蒸餾水, 且如上進行萃取。每一樣品進行三次熱水萃取,將所得濾 液混合,於真空下濃縮至適量體積,計算濃縮率並紀錄之 〇 實驗組:機械式研磨整株靈芝子實體,包含以下步驟 步驟(一)研磨前處理。 秤取靈芝子實體,洗淨切丁後加入250 mL 4°C去離子 水,以授碎器(Blender 7012S, Waring Commercial, USA) 攪打5分鐘後倒入600 mL的高型燒杯中,以去離子水( 150 mL、)將殘留在攪碎器中的子實體粗碎物洗出,於 4°C下靜置隔夜,使纖維組織鬆弛,再以高速均質機( Polytron PT 3000, Kinematica AG, Switzerland)於 20,000 rpm下攪打10分鐘(全程冰浴以避免溫度上升),使子實體 顆粒小於300 μηι,再進行機械式研磨。 步驟(二)機械式研磨。 201036621 使用奈米細磨機(MiniPur,NETZCH- Feinmahltechnik GmbH, German)研磨上述步驟(一)所得之子實體顆粒, 研磨需分為二個階段。第一階段使用粒徑0.8 mm之釔锆珠 為研磨介質,第二階段則改用粒徑0.3 mm之釔锆珠為研磨 介質,進料速度360 mL/min。為探討操作條件對產品之影 響,選擇不同的固形物濃度、研磨介質填充量及攪拌轴轉 速進行實驗,於研磨過程中,每30分鐘取樣進行粒徑分析 〇 〇 完成上述靈芝子實體懸浮液之製備後,將針對對照組 與實驗組所得之靈芝液進行化性與物性分析比較,分別如 下所述: (一)化性分析 Α· β-葡聚糖(β-D-glucans)含量測定 利用螢光染劑Aniline blue定量β-葡聚糖。取研磨後之 靈芝子實體懸浮液離心( 2000xg, 10 min)後,以Whatman No.4濾紙過滤,取適量樣品溶液,加入0.3 N NaOH使總體 〇 W 積為3 mL,攪拌30分鐘,以1 N HC1調整pH至11.5,加 入 50 mM 之 pH 11.5 的 Na2HP04-Na0H buffer (含 0.5 Μ NaCl),並定容至10 mL。取上述溶液2 mL,加入0.2 mL aniline blue ( 1 mg/mL ),以Vortex震蘯混合均勻後,靜置 2小時,以螢光檢測器檢測(激發波長395 nm,放射波長 * 495 nm )。以不同濃度之Lentinan製備標準曲線,計算樣品 • 中之β-葡聚糖含量。 Β.總膳食纖維測定 7 201036621 採用 AOAC 991.43 (enzymatic-gravimetric method)和 AOAC 993.21 ( nonenzymatic-gravimetric method)兩種方法201036621 VI. Description of the Invention: [Technical Field] The present invention relates to a ganoderma lucidum liquid, which is a suspension of a body of Ganoderma lucidum produced by mechanical grinding. ^ [Prior Art] Ο Nano/submicron products are a hot topic in recent years. In recent years, the attention of research scholars, operators and the general public has the importance and potential of nano/sub-microtechnology. Many countries have Prior research on nano/submicron technology is a priority, and – the application of nano/submicron technology to food materials will revolutionize the global food system, although currently nano/submicron The research on food materials is still in its infancy, but after the particles of the food are small, it should increase the absorption rate, and help the infants, the elderly or the digestive system to get the necessary nutrients, and it can be applied to the Chinese herbal medicine to make it easier to play. In order to achieve this long-term goal of the county's recognition of ημ Α 'jw two, the understanding of nano/sub-micron technology and product properties of food materials is an important issue. In Chinese herbal medicine, Ganoderma lucidum fruit body shells have been publicly advertised as having many health functions such as anti-tumor, regulating immune function, limiting nt cabin, lowering blood fat, lowering blood pressure, lowering blood sugar, anti-virus, anti-allergy, anti-oxidation, Anti-light shot, inhibition of platelet clotting and analgesia, whether it is eaten with intact fruiting bodies or extracts, it is safe to use Chinese herbal medicines, even high doses, such as: dried fruit extracts per 曰%^, It was confirmed that there was no significant toxicity, and the nutritional value and toxicity of Ganoderma lucidum were evaluated by animal experiments. The results showed that Ganoderma lucidum had no genotoxicity. It is estimated that the production of Ganoderma lucidum in the world was ridiculed in 2001. China's Big 3 201036621 is the largest producer (3,500 tons), and about 2 million people consume Ganoderma lucidum, which consumes about 2.5 kilograms per person per year. The increase in consciousness will make the market of Ganoderma lucidum products grow year by year. However, there are many kinds of Ganoderma lucidum products on the market. The common ones are: whole ganoderma lucidum, ganoderma lucidum slices, capsules, granules, ingots and liquid drinks (Ganoderma lucidum tea, Ganoderma lucidum wine, Ganoderma lucidum syrup and Ganoderma lucidum beverage), etc. In terms of quality, the quality is not good. Although Ganoderma lucidum health food is a popular commodity in the current food market, its active ingredients (such as chitin, sugar-supplying, β-glucan) are difficult to extract, have low solubility, and are not well absorbed in the human body, and are extracted. The latter ganoderma slag (mostly the ingredient of dietary fiber) is often regarded as waste, which causes waste of resources. According to the applicant's research, if the complete Ganoderma lucidum fruit body particle size nano/submicron treatment can be made into nano/sub-micron Ganoderma lucidum fruit body suspension, not only help the release of active ingredients such as Ganoderma lucidum polysaccharide, In addition to obtaining the complete active ingredient and increasing the absorption and utilization of the active ingredient, it is also possible to obtain nano/micronized dietary fiber therefrom while reducing waste generation. SUMMARY OF THE INVENTION Accordingly, it is an object of the present invention to provide a suspension of Ganoderma lucidum fruit body which is produced by mechanical grinding and which has fine ganoderma lucidum particles. Another object of the present invention is to provide a suspension of Ganoderma lucidum fruit body which is produced by mechanical grinding and has nano/submicron, graded ganoderma lucidum particles. Thus, the suspension of the Ganoderma lucidum fruit body of the present invention is obtained by mechanically grinding the Ganoderma lucidum fruit body to obtain a suspension of Ganoderma lucidum fruit bodies containing the ganoderma lucidum particles, and contains cellulosic, chitin, and β-glucan, and the ganoderma lucidum particles The volume average particle size is less than 10 μηη. 201036621 Thus, the nano/sub-micron-sized suspension of Ganoderma lucidum fruit body of the present invention is a centrifugal supernatant obtained by mechanically grinding a ganoderma lucidum fruit body suspension containing Ganoderma lucidum, and then centrifuging. The nano/sub-micron Ganoderma lucidum fruit body suspension contains cellulosic, chitin, and glucan, and the volume average particle size of the ganoderma lucidum particles is less than 2 μm. The effect of the invention: the method for manufacturing the suspension liquid of the ganoderma lucidum fruit body by mechanical grinding, in addition to obtaining the complete active ingredient without extracting, the fiber specific surface area can be greatly improved, and the subsequent utilization of the fiber material does not need to be pulverized again. Can be used as a good dietary fiber supplement. The above and other technical contents, features, and advantages of the present invention will be apparent from the following detailed description of the preferred embodiments. The preferred embodiment of the suspension of the Ganoderma lucidum fruit body of the present invention is prepared by mechanically grinding the entire Ganoderma lucidum fruit body suspension, and the Ganoderma lucidum fruit body suspension comprises the Ganoderma lucidum microparticles obtained by mechanically grinding the Ganoderma lucidum fruit body, and An edible emulsifier that is ground together with the fruiting body of Ling. Mechanical nano-grinding is the use of mechanical energy, the collision between the grinding medium (abrasive beads) and the cutting force between the slurry_fluid and the fluid grinding beads to break and disperse large particles, often used in coatings or nanopowders. Preparation. The mechanical grinder is equipped with a cooling system to avoid high temperatures and facilitate the treatment of heat sensitive organic materials such as food materials and Chinese herbal medicines. The following is an extract obtained by a conventional hot water extraction method, and the present invention directly compares the Ganoderma lucidum fruit body suspension after mechanically grinding the nano/micron treatment of the Ganoderma lucidum fruit body. Control group: traditional hot water extraction, the Ganoderma lucidum fruit body was washed and placed in 7 (TC oven, dried by hot air to about 10% residual moisture. Using a crusher (RT-04, Rong Tsong Iron Co., Taiwan) Powdered for use. Take 300 g of Ganoderma lucidum fruit body powder, add 4500 mL of steamed water, heat at 100 °C for 2 hours, heat it with 60 mesh sieve, and then use the sputum to filter with Whatman No.4 (paper) Whatman, Springfield Mill, UK) Filtration to remove the fine residue, the yellow filtrate is obtained as the extract, and the residue is further added with 4500 mL of distilled water and extracted as above. Three hot water extractions are performed for each sample, and the filtrate is mixed. Concentrate to a suitable volume under vacuum, calculate the concentration rate and record the experimental group: mechanically grind the entire Ganoderma lucidum fruiting body, including the following steps (1) pre-grinding. Scale the ganoderma lucidum fruiting body, wash the diced and add 250 mL 4 ° C deionized water, whipped with a shredder (Blender 7012S, Waring Commercial, USA) for 5 minutes, then poured into a 600 mL high-profile beaker, with deionized water (150 mL,) remaining in the stir Fruiting body in the shredder The coarse material was washed out, allowed to stand overnight at 4 ° C, the fibrous structure was relaxed, and then whipped at 20,000 rpm for 10 minutes with a high speed homogenizer (Polytron PT 3000, Kinematica AG, Switzerland) (full temperature ice bath to avoid temperature) Rise), the sub-solid particles are less than 300 μηι, and then mechanically ground. Step (2) Mechanical grinding. 201036621 Grinding the sub-step (1) using a nano-fine grinding machine (MiniPur, NETZCH-Feinmahltechnik GmbH, German) For solid particles, the grinding is divided into two stages. In the first stage, cerium-zirconium beads with a particle size of 0.8 mm are used as grinding media, and in the second stage, cerium-zirconium beads with a particle diameter of 0.3 mm are used as grinding media, and the feed rate is 360 mL. /min. In order to explore the influence of operating conditions on the product, select different solid concentration, grinding medium filling amount and stirring shaft speed for experiment. During the grinding process, sample the particle size every 30 minutes to complete the above-mentioned Ganoderma lucidum fruiting body. After the preparation of the suspension, the chemical and physical properties of the control group and the experimental group were compared and analyzed as follows: (1) Α·β-glucan (β-D-glucans) content determination β-glucan was quantified by fluorescent dye Aniline blue. After centrifugation of the ground Ganoderma lucidum fruit body suspension (2000×g, 10 min), Filter No.4 filter paper, take appropriate amount of sample solution, add 0.3 N NaOH to make the total 〇W product 3 mL, stir for 30 minutes, adjust the pH to 11.5 with 1 N HC1, add 50 mM Na2HP04-Na0H buffer with pH 11.5 (including 0.5 Μ NaCl) and bring up to 10 mL. 2 mL of the above solution was added, 0.2 mL of aniline blue (1 mg/mL) was added, mixed with a Vortex shake, and allowed to stand for 2 hours, and detected by a fluorescent detector (excitation wavelength 395 nm, emission wavelength * 495 nm). The β-glucan content of the sample was calculated by preparing a standard curve with different concentrations of Lentinan. Β. Determination of total dietary fiber 7 201036621 Using AOAC 991.43 (enzymatic-gravimetric method) and AOAC 993.21 (nonenzymatic-gravimetric method)

。AOAC 991.43是目前廣為學者所接受之測定方法,AOAC 993.21則是一種不使用酵素的簡便方法(此法只適用於總 膳食纖維> 10% ’澱粉< 2%之樣品’包括靈芝之部分中草 藥均符合此規範)。 C.幾丁質(Chitin)含量測定 取400 mg靈芝子實體懸浮液,以6 N HC1於1 〇〇。〇下 迴流水解5小時,冷卻至室溫後以Whatman No.4濾紙過渡 ,取1 mL濾液於45〜50°C下減壓乾燥後備用。將乾燥之水 解產物回溶於蒸館水中。取1 mL上述水解產物之稀釋溶液 加入 0.25 mL 4% acetylacetone,於 90°C下加熱 1 小時,冷 卻後加入2 mL ethanol並震盪使沉澱物溶解,隨後加入0.25 mL Ehrlich reagent,呈色後,於波長530 nm下測定其吸光 值。利用不同濃度之 glucosamine hydrochloride ( 5〜50 pg/mL)製作標準曲線,並以 l,4-anhydro-N-acetyl-2-deoxy-D-glucopyranose equivalent 計算幾丁質含量。 (二)物性分析 A.粒徑分佈測定 使用動態光散射粒徑分析儀(dynamic light scattering particle size analyzer) ( Nanotrac 150, Microtrac Inc., USA) ,測定所得之靈芝微粒的粒徑分佈,該儀器的測定範圍0.8 nm至6500 nm。如超出該範圍,貝1J改用Beckman Coulter (CA,USA)生產之LS 230粒徑分析儀進行量測,其粒徑 201036621 量測範圍0.4 μιη至2000 μιη,光源經濾光處理後,偵測下 限可達40 nm。以去離子水作為空白測試,並於25°C下進行 測定。將研磨後之靈芝子實體懸浮液經適當稀釋後,直接 以儀器測定之。利用分析軟體(FLEX Software, Microtrac Inc., USA)分析散射訊號,計算粒子之Doppler shifts以求 得粒徑分佈百分比、平均粒徑(mean particle size )、中間 粒徑(median particle size )等粒徑分佈參數。 B.顯微觀察 〇 使用光學顯微鏡(Optiphot-Pol, Nikon, Japan )觀察靈 芝粗碎後之組織結構,以及研磨初期靈芝顆粒之變化情形 。以掃描式電子顯微鏡(SEM)觀察所得靈芝微粒的顯微結 構。樣品經稀釋後,塗抹於載玻片上,置於室溫下乾燥, 用銀膠將樣品黏著於鋁台上,於真空狀態下以離子覆膜器 將樣品表面鍍上金膜後,以SEM觀察樣品之顯微結構。另 亦使用穿透式電子顯微鏡(TEM ) ( JEM-1230,JEOL Co. Ltd, Japan)觀察所得靈芝微粒之顯微結構,確認粒徑分佈 Ο 之測量結果。樣品經適當稀釋後,以TEM專用之200 mesh 鑛碳銅網( 01800-F, Ted Pella, Inc·,U.S.A.)沾取樣品懸浮 液,置於乾燥箱中乾燥,乾燥後之樣品直接以TEM觀察, 並以 CCD 照相系統(DualVision CCD, Gatan Inc·, USA )拮 取所需之數位影像。TEM所用之電子源為熱陰極電子槍(. AOAC 991.43 is currently accepted by a wide range of scholars. AOAC 993.21 is a simple method of not using enzymes (this method is only applicable to total dietary fiber) 10% 'starch< 2% of samples' including parts of Ganoderma lucidum Chinese herbal medicines meet this specification). C. Chitin content determination Take 400 mg of Ganoderma lucidum fruit body suspension with 6 N HC1 at 1 〇〇. The mixture was refluxed and hydrolyzed for 5 hours, cooled to room temperature, and then transferred to Whatman No. 4 filter paper. 1 mL of the filtrate was dried at 45 to 50 ° C under reduced pressure and used. The dried hydrolyzed product is dissolved back into the steaming water. Add 1 mL of the diluted solution of the above hydrolyzate to 0.25 mL of 4% acetylacetone, heat at 90 °C for 1 hour, add 2 mL of ethanol after cooling, and shake to dissolve the precipitate, then add 0.25 mL of Ehrlich reagent, after coloring, The absorbance was measured at a wavelength of 530 nm. Standard curves were prepared using different concentrations of glucosamine hydrochloride (5 to 50 pg/mL) and chitin content was calculated as l,4-anhydro-N-acetyl-2-deoxy-D-glucopyranose equivalent. (2) Physical property analysis A. Particle size distribution measurement The particle size distribution of the obtained ganoderma lucidum microparticles was measured using a dynamic light scattering particle size analyzer (Nanotrac 150, Microtrac Inc., USA). The measurement range is from 0.8 nm to 6500 nm. If it is outside this range, Bayi 1J is measured by LS 230 particle size analyzer manufactured by Beckman Coulter (CA, USA). Its particle size is 201036621. The measurement range is 0.4 μιη to 2000 μιη. After the light source is filtered, it is detected. The lower limit is up to 40 nm. Deionized water was used as a blank test and measured at 25 °C. After the ground suspension of the Ganoderma lucidum fruit body is properly diluted, it is directly measured by an instrument. The analysis software (FLEX Software, Microtrac Inc., USA) was used to analyze the scattering signals, and the Doppler shifts of the particles were calculated to obtain the particle size distribution percentage, the mean particle size, the median particle size, and the like. Distribution parameters. B. Microscopic observation 〇 The optical structure (Optiphot-Pol, Nikon, Japan) was used to observe the structure of the crude ganoderma lucidum and the change of the ganoderma lucidum particles in the initial stage of grinding. The microstructure of the obtained Ganoderma lucidum microparticles was observed by a scanning electron microscope (SEM). After the sample is diluted, it is applied to a glass slide, dried at room temperature, and the sample is adhered to the aluminum table with silver glue. The surface of the sample is plated with a gold film by an ion laminator under vacuum, and observed by SEM. The microstructure of the sample. The microstructure of the obtained Ganoderma lucidum microparticles was also observed using a transmission electron microscope (TEM) (JEM-1230, JEOL Co. Ltd, Japan), and the measurement results of the particle size distribution Ο were confirmed. After the sample is properly diluted, the sample suspension is taken up by a TEM-specific 200 mesh mineral carbon copper mesh (01800-F, Ted Pella, Inc., USA), dried in a dry box, and the dried sample is directly observed by TEM. The desired digital image was obtained by a CCD camera system (DualVision CCD, Gatan Inc., USA). The electron source used in TEM is a hot cathode electron gun (

LaB6燈絲),最大加速電壓為120 KV。 (三)靈芝子實體懸浮液之穩定性處理與分析 A.界面活性劑之添加 9 201036621 選擇適當的研磨操作條件(轉速:36〇〇 rpm,介質直 徑:0.2 mm;時間:9〇分鐘),於研磨前加入不同種類、濃 度和HLB值之可食性乳化劑。選用之乳化劑有:丨離子型 界面活性劑(ionic surfactant ),例如脂肪酸鹽類(屬陰離 子型界面活性劑)。2.非離子型界面活性劑(n〇ni〇nie SUrfaCtant),例如(1 )蔗糖酯(sugar ester)(選擇 HLB 值 刀別為3、7、11和15之蔗糖酯);(2)聚山梨醇酐脂肪酸 S曰(Span 85、80、60、20 和 Tween 65、20 ’ HLB 值分別為 1·8 4·3、6.7、8.6、10.6、16.7 )。上述所選用之乳化劑濃 度,是以研磨之固形物含量為基礎,加入5%、1〇%、2〇% 和 50%。 Β·儲存性試驗 將研磨後及經穩定處理之靈芝子實體懸浮液分別放置 在4°C和室溫下,於儲存期間(〇、〇 5、丨、2、6、12、24 72 96小時),取樣進行濁度分析和粒徑分析。於此 5式驗中,將添加少許防腐劑,以避免微生物的生長。 c.濁度測定 濁度的高低與溶液中粒子之數量有關,若樣品中之奈 米/次微米粒子聚集成大粒+,甚至沉;殿,則懸浮粒子總數 下降致使上層溶液濁度下降。可由濁度初步判斷靈芝子 實體懸浮液之穩定性’進而淘汰不適用的乳化劑。使用攜LaB6 filament) with a maximum accelerating voltage of 120 KV. (III) Stability treatment and analysis of suspension of Ganoderma lucidum fruiting body A. Addition of surfactant agent 9 201036621 Select appropriate grinding operation conditions (rotation speed: 36 rpm, medium diameter: 0.2 mm; time: 9 〇 minutes), Edible emulsifiers of different types, concentrations and HLB values were added prior to milling. The emulsifiers used are: ionic surfactants, such as fatty acid salts (anionic surfactants). 2. Non-ionic surfactant (n〇ni〇nie SUrfaCtant), for example (1) sugar ester (selecting sucrose esters with HLB values of 3, 7, 11 and 15); (2) The sorbitan fatty acid S曰 (Span 85, 80, 60, 20 and Tween 65, 20 'HLB values are 1·8 4·3, 6.7, 8.6, 10.6, 16.7). The emulsifier concentration selected above is based on the solid content of the mill and is added at 5%, 1%, 2% and 50%. Β·Storage test The ground and stabilized Ganoderma lucidum fruit body suspensions were placed at 4 ° C and room temperature during storage (〇, 〇5, 丨, 2, 6, 12, 24 72 96 hours) , sampling for turbidity analysis and particle size analysis. In this type 5 test, a small amount of preservative will be added to avoid the growth of microorganisms. c. Turbidity measurement The level of turbidity is related to the amount of particles in the solution. If the nano/submicron particles in the sample aggregate into large particles + or even sink; the total number of suspended particles decreases, causing the turbidity of the upper solution to decrease. The stability of the solid suspension of Ganoderma lucidum can be judged by turbidity, and the emulsifier which is not suitable can be eliminated. Use

f 良濁度 °十(P〇rtable turbidimeter,model 2100P, HACH p y,u’s·a.)測疋儲存期間濁度的變化,檢測前先以標f Good turbidity °T (P〇rtable turbidimeter, model 2100P, HACH p y, u’s·a.) Measure the change of turbidity during storage, before the detection

準口u (Gelex Secondary Standards)(濁度分別為 〇_ 1〇 NTU 10 201036621 、0-1的NTU和0_ 1000 NTU)校正,取研磨及穩定處理後 之靈芝子實體懸浮液,經適當稀釋’取15 mL置入水樣檢 測瓶中,直接以濁度計測定之,單位為NTU。 D.界面電位(zeta potential)測定 界面電位是粒子間吸引力或排斥力的指標,該值的增 力”員示粒子越穩定,是測量粒子表面性質的有效工具。 將稀溶液置於偵測儀上,賦予粒子固定值的電壓,觀察粒 子的移動速率,由移動速率與時間的相關性,可導出粒子 表面的相關性質。界面電位分析儀(Zeta⑽印制⑽办抓 )可即時分析界面電位對應pH值、乳化劑添加濃度及時間 的變化曲線圖及結果,由於界面電位之測定為奈米/次微米 粒子穩定性的重要指標,藉由該數據的分析,可推論出奈 米/次微米級靈芝微粒再聚集的可能原因,進而探討其基礎 理論。配合現有之濁度計及雷射粒徑分析儀等,將可使產 品穩定性之解析更加完備且具時效性,同時瞭解奈米/次微 米級靈芝微粒的表面特性,是將來進一步修飾粒子表面性 質的重要依據。 E·顯微觀察 使用光學顯微鏡(〇ptiph〇t_p〇1,Nik〇n, Japan)觀察奈 米/次微米級靈芝微粒再聚集之變化情形。此外,以穿透式 電子顯微鏡(TEM) ( jEM_1230, JEOL c〇 Ltd,Japan)觀察 儲存期間奈米/次微米級靈芝微粒的顯微結構’以確認粒徑 刀佈的測量及再聚集之結構,並以掃描式電子顯微鏡( Scannmg electron micr〇sc〇pe,SEM )觀察所得樣品的顯微結 11 201036621 構0 (四)28天亞急毒性試驗 依衛生署公告的「藥品非臨床試驗優良操作規範」,和 「健康食品安全性評估方法」中的毒性試驗方法進行28天 亞急毒性試驗。在試驗物質給予期間測量動物體重及食物 消耗量之變化。剖檢前收集血液樣品,進行血液及血清生 化分析。試驗物質給予期間結束,進行剖檢,以肉眼觀察 及記錄動物的器官與組織之變化,並測量主要臟器重量。 最咼劑量組與對照組進行組織病理檢驗。 A.動物處理 動物則採用自台大醫學院動物中心的5_6週ICR小鼠 ’每劑量組㈣雄、雌各12隻動物。在進行毒性測試前^ 動物首先在具溫度、溼度及光照之動物房適應一週,並自 由攝取正常飼料及水。一週後開始餵食實驗,連續Μ天後 ,犧牲小鼠。 Β·靈芝劑量 在本試驗中,低劑量及中劑量組則分別採〇 〇2及〇 2 g/kg/day,高劑量組採用2 g/kg/day。此低劑量(〇 g/kg/day)、中劑量(0_2 g/kg/day)、高劑量(2 g/kg/day) 分別為成人每日建議攝取量之同劑量、1〇倍及1〇〇倍。 C.血清生化值之測定 動物的血液樣本取自頸動脈血放入血清分離管,、奸 3000 xg 15分鐘離心後取的血清樣本。分析項目如下:古〜 度脂蛋白(high density lipoprotein,HDL )、低密度脂蛋白 12 201036621 (low density lipoprotein, LDL )、麵氨酸氨基轉化酶( glutamic oxaloacetic transaminase, GOT)、越氨酸丙酮酸氨 基轉化酶(glutamic pyruvic transaminase, GPT)、血液尿素 氮(blood urea nitrogen,BUN )、肌氨酸酐(creatinine, CRE )、總膽固醇(cholesterol,CHO )、三酸甘油脂 ( triglyceride, TG)、鈉離子(Na+ )、鉀離子(K+)、氣離子 (C1-)、葡萄糖(Glucose)等。 D. 血液分析Correction of Gelex Secondary Standards (turbidity 〇 1 〇 NTU 10 201036621, NTU of 0- 1 and 0_1000 NTU), taking the ground and stabilized suspension of Ganoderma lucidum fruit body, diluted appropriately Take 15 mL into the water sample test bottle and measure it directly by turbidity meter, the unit is NTU. D. Zeta potential Determination of interface potential is an indicator of the attraction or repulsive force between particles. The enhancement of this value indicates that the more stable the particle is, it is an effective tool for measuring the surface properties of the particle. On the instrument, the voltage of the fixed value of the particle is given, and the moving rate of the particle is observed. The correlation between the moving rate and the time can be used to derive the relevant properties of the particle surface. The interface potential analyzer (Zeta (10) printing (10) can analyze the interface potential in real time. Corresponding to the pH value, emulsifier concentration and time curve and results, since the measurement of the interface potential is an important indicator of the stability of the nano/submicron particles, the analysis of the data can infer the nano/submicron. The possible reasons for the re-aggregation of Ganoderma lucidum particles, and then explore its basic theory. With the existing turbidity meter and laser particle size analyzer, the analysis of product stability can be more complete and time-sensitive, and understand nano/ The surface characteristics of submicron-sized Ganoderma lucidum particles are an important basis for further modification of the surface properties of particles in the future. E·Microscopic observation using optical microscopy 〇ptiph〇t_p〇1, Nik〇n, Japan) Observed changes in the re-aggregation of nano/sub-micron Ganoderma lucidum particles. In addition, observation by a transmission electron microscope (TEM) (jEM_1230, JEOL c〇Ltd, Japan) The microstructure of the nano/sub-micron-sized Ganoderma lucidum particles during storage was confirmed by the measurement and re-aggregation of the particle size cloth, and the obtained sample was observed by a scanning electron microscope (Scannmg electron micr〇sc〇pe, SEM). Microscopy 11 201036621 Structure 0 (4) 28-day sub-acute toxicity test according to the "Good Practices for Non-Clinical Testing of Drugs" announced by the Department of Health, and the toxicity test method in the "Method for Assessment of Health Food Safety" for 28 days. Toxicity test. Changes in animal body weight and food consumption were measured during the administration of the test substance. Blood samples were collected prior to necropsy for blood and serum biochemical analysis. At the end of the test substance administration period, a necropsy was performed to visually observe and record changes in the organs and tissues of the animals, and measure the weight of the main organs. Histopathological examination was performed in the last dose group and the control group. A. Animal treatment Animals were used for 5-6 weeks ICR mice from the Animal Center of National Taiwan University Medical College. Each dose group (four) male and female 12 animals. Before the toxicity test, the animals were first acclimatized for one week in an animal room with temperature, humidity and light, and freely ingested normal feed and water. The feeding experiment was started one week later, and the mice were sacrificed after a continuous day. Β·Ganoderma Lucidum In this trial, the low-dose and medium-dose groups were 〇2 and 〇 2 g/kg/day, respectively, and the high-dose group was 2 g/kg/day. The low dose (〇g/kg/day), medium dose (0_2 g/kg/day), and high dose (2 g/kg/day) are the same daily doses, 1〇 times, and 1 for the recommended daily intake of adults. 〇〇 times. C. Determination of serum biochemical value The blood sample of the animal was taken from the carotid artery blood into a serum separation tube, and the serum sample taken after centrifugation at 3000 xg for 15 minutes. The analysis items are as follows: high density lipoprotein (HDL), low density lipoprotein 12, 201036621 (low density lipoprotein, LDL), glutamic oxaloacetic transaminase (GOT), valine pyruvate Glutamic pyruvic transaminase (GPT), blood urea nitrogen (BUN), creatinine (CRE), total cholesterol (cholesterol, CHO), triglyceride (TG), sodium Ions (Na+), potassium ions (K+), gas ions (C1-), glucose (Glucose), and the like. D. Blood analysis

動物的血液樣本取自頸動脈血放入含EDTA抗凝劑試 管採集1 mL全血,分析項目如下:白血球(white blood cell, WBC )、紅血球(red blood cell,RBC )、血紅素( hemoglobin, Hb)、血球容積比(hematocrit, Hct)、平均紅 血球容積(mean corpuscular, MCV)、平均紅血球血紅素( mean corpuscular hemoglobin, MCH)、平均紅血球血紅球濃 度(mean corpuscular hemoglobin concentration, MCHC)、 血小板(platelets,PLT )、淋巴球數目(lymphocytes, LYMPH )、紅血球平均寬度(red cell distribution width-coefficient of variation, RDW-CV)、 jk 小板 紅血球 (platelet distribution width, PDW)、平均血小板容積(mean platelet volume, MPV )、血小板大細胞範圍(platelet-large cell range, P-LCR)等。 E. 組織病理切片 將所有動物之組織,肝臟、腎臟、心臟、脾臟、肺臟 、睪丸、副睪及子宮卵巢等標的器官取下後,放入10% 13 201036621 formalin固定一星期。切片後以hemat〇xylin and如加染色 後’以顯微鏡觀察。組織病理切片判讀委託台灣動物科技 研究所進行。 以下即針對本發明靈芝子實體懸浮液之製程與分 行說明: (一)、研磨製程與粒徑之關係 如表1所示研磨條件,於相同研磨時間(90 min )下, 探討轉速(2310〜3570 rpm)、進料濃度(〇.5〜2 〇 g/mL) 和研磨珠填充量(80〜14〇 mL)對靈芝奈米/次微米化製程 之影響。 表1 編號 離心轉速 (rom ) 靈芝進料濃度 (g/mL ) 研磨珠填充量 (mL ) 1 3570 0.5 140 2 3570 0.5 110 — 3 3570 0.5 80 4 3570 1.0 140 5 3570 2.0 140 6 7 2940 1 η 0.5 140 如圖1所示,轉速提高會增加研磨珠間的碰撞次數和 強度,致使溫度快速上升並促使粒子再聚集,造成平均粒 徑的增加。提高進料濃度可降低粒子間的平均距離並使研 磨珠碰撞範圍内存在較多的粒子而增加研磨效率。填充量 過高則可能會限制研磨珠於研磨過程中的運動,降低碰撞 速度,致使研磨效率降低。由上述實驗結果可知在奈米/ 次微米級靈芝子實體懸浮液的研磨製程中,使用較高的固 形物濃度,並降低研磨轉速及研磨珠的填充量,應可降低 產品的體積平均粒徑。 14 201036621 將前述前處理所得之靈芝細碎懸浮液於36〇〇 rpm之固 定轉速、360 mL/min之固定進料速率和14〇 之固定填充 量,以及不同固形物濃度與兩種研磨珠大小(0.8 mm、0.3 mm 釔锆珠)下研磨 3〇、6〇、9〇、12〇、15〇、18〇 和 分 鐘。發現經前處理後之靈芝細碎懸浮液,其粒徑雖可小於 300 μιη,但絕大部分仍大於15〇 μιη,因此,欲將靈芝子實 體奈米/次微米化需採用階段性研磨,亦即先以酿紀結 珠細磨,待粒徑降至約5〇 μ〇1以下 繼續研磨。Animal blood samples were taken from carotid blood and 1 mL of whole blood was collected from EDTA anticoagulant tubes. The analysis items were as follows: white blood cell (WBC), red blood cell (RBC), hemoglobin (Hb) ), hematocrit (Hct), mean corpuscular (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), platelets (platelets) , PLT), lymphocytes (LYMPH), red cell distribution width-coefficient of variation (RDW-CV), jk platelet distribution width (PDW), mean platelet volume (mean platelet volume) , MPV), platelet-large cell range (P-LCR), and the like. E. Histopathological section The organs of all animals, liver, kidney, heart, spleen, lung, testicular, parasitoid and uterus and ovary were removed and placed in 10% 13 201036621 formalin for one week. After sectioning, hemat xylin and staining were added as 'microscopically observed'. Histopathological section interpretation was commissioned by the Taiwan Institute of Animal Science and Technology. The following is a description of the process and branch of the suspension of Ganoderma lucidum fruit body of the present invention: (1) The relationship between the grinding process and the particle size is as shown in Table 1. Under the same grinding time (90 min), the rotation speed is discussed (2310~) The effect of 3570 rpm), feed concentration (〇.5~2 〇g/mL) and grinding bead loading (80~14〇mL) on the Ganoderma lucidum nano/micronization process. Table 1 No. Centrifugal speed (rom) Ganoderma lucidum feed concentration (g/mL) Grinding beads filling amount (mL) 1 3570 0.5 140 2 3570 0.5 110 — 3 3570 0.5 80 4 3570 1.0 140 5 3570 2.0 140 6 7 2940 1 η 0.5 140 As shown in Figure 1, an increase in the number of revolutions increases the number and intensity of collisions between the beads, causing the temperature to rise rapidly and causing the particles to reaggregate, resulting in an increase in the average particle size. Increasing the feed concentration reduces the average distance between the particles and results in more particles in the impact zone of the grinding beads, increasing the grinding efficiency. Excessive filling may limit the movement of the beads during the grinding process and reduce the collision speed, resulting in reduced grinding efficiency. It can be seen from the above experimental results that in the grinding process of the nano/sub-micron-sized Ganoderma lucidum fruit body suspension, the use of a higher solid concentration, and the reduction of the grinding speed and the filling amount of the grinding beads should reduce the volume average particle diameter of the product. . 14 201036621 The above-mentioned pretreatment of the finely ground suspension of Ganoderma lucidum at a fixed rotation speed of 36 rpm, a fixed feed rate of 360 mL/min and a fixed filling amount of 14 ,, and different solid concentration and two kinds of grinding beads ( 0.8 mm, 0.3 mm yttrium zirconium beads were ground 3 〇, 6 〇, 9 〇, 12 〇, 15 〇, 18 〇 and minutes. It was found that the pre-treated Ganoderma lucidum finely divided suspension had a particle size of less than 300 μm, but most of it was still larger than 15 μm. Therefore, it is necessary to use staged grinding for the nano/submicron of the Ganoderma lucidum fruiting body. That is, the fine grinding is first performed with the granules, and the grinding is continued until the particle size falls below about 5 〇μ〇1.

再改以0.3 mm紀錯珠 、如圖2所示’研磨時間亦影響粒徑,隨著研磨時間的 增加,體積平均粒徑減少,於研磨6G分鐘,體積平均粒徑 之減少速率較高,隨後趨緩,研磨9〇分鐘後,靈芝微粒之 體積平均粒徑約為丨.2陴。繼之改以G 3 _锆珠研磨9〇 分鐘後,則體積平均粒徑小於1G μηι。因所㈣浮液之粒 徑分佈範圍較寬,故粒子間易再聚集而沉澱,雖然數目平 均粒徑比體積平均粒徑小很多,但為求更佳的品質,本發 明是以體積平均粒徑為指標。 由圖3、4所示之粒捏分析結果可知,將上述以〇 3麵 釔鉛珠研磨刚分鐘所得靈芝子實體懸浮液以麵呂離心 1〇分鐘,除去較大之顆粒後,離心上清k粒徑分佈· 為28〜578 nm (圖3 ),體銪承的私斤从 體積千均粒徑約105 nm,其中67% 的粒子小於100 nm,就食品 °』、於1 μιη應足可增加其 於體内的吸收,離心上清、、存夕私工 ,月液之粒子皆小於1 μη!,其固形物 含量雖較低,但因研磨而被萃提出 平扠出之活性成分則皆仍存留 15 201036621 下來°而離心降物之顆粒尺寸小於1G_ (圖4),質地 細緻,可作為保養品(如面膜)或敷料、人工皮膚之基材 給且因富含幾丁質及纖維素’所以可作為一良好的腾食纖 維添加物。 如圖5所示,顯微觀察研磨後之靈芝微粒,新鮮靈芝 子實體經blender携打後,以掃描式電子顯微鏡(SEM)觀 察’由圖5B中清楚可見靈芝子實體之樹狀分枝骨路菌絲。 經適當均質處理後,該骨路菌絲變的更為細碎、鬆散(如 =5C所不),且其大小約在數十至數百微米,而此-狀態 將有利於後續之研磨處理。圖5D為經兩段式研磨後,利用 穿透式電子顯微鏡(TEM)觀察之結果,圖中圓形顆粒為 靈之子實體懸浮液中的奈米粒子,由純-可明顯的看 到,單一顆粒確可達〇.1μιη以下之奈米級尺度,但因顆粒 間的再聚集使整體之粒徑範圍變大’可達數百奈米,即為 次微米級尺度。此一結果亦驗證了上述粒徑分析儀所測得 之結果,並再次確認本發明使用之介質研磨製程,確實可 使靈芝子實體研磨後之靈芝微粒降至奈米/次微米尺度。 由於靈芝子實體富含纖維素及幾丁質質地粗糙且堅 勒,將這些纖維物質的粒徑下降,除提高比表面積外,亦 可改善產品進食之口感。勝食纖維之生理功效與其表面之 吸附作用有關,因此,提高腾食纖維之比表面積,可増進 其生理活性。將膳食纖維之粒徑由〇1麵下降至i㈣比 表面積可提尚1〇〇倍’勝食纖维之建議攝取量則可減為原 建議量的百分之一,若粒徑下降至100 nm以下,建議攝取 16 201036621 量則可減至原建議量的千分之一。換言之,於500 mL之飲 用水中加入50 ~ 500 ppm之奈米/次微米級膳食纖維,即可 達到膳食纖維之每日建議攝取量(25 g)。基於這個觀點, 靈芝子實體懸浮液之離心上清液不但保有靈芝特有的生理 活性成分,更額外提供高表面積之膳食纖維。 (二)研磨製程與有效成分之關係Then change to 0.3 mm error beads, as shown in Figure 2, the grinding time also affects the particle size. As the grinding time increases, the volume average particle size decreases. At 6G minutes of grinding, the volume average particle size decreases at a higher rate. After slowing down, after grinding for 9 minutes, the volume average particle size of the ganoderma lucidum particles is about 丨.2陴. After grinding for 9 minutes with G 3 _ zirconium beads, the volume average particle size is less than 1 G μηι. Because the particle size distribution range of the (IV) floating liquid is wide, the particles are easily aggregated and precipitated. Although the number average particle diameter is much smaller than the volume average particle diameter, in order to obtain better quality, the present invention is a volume average particle. The diameter is an indicator. From the results of the granule pinch analysis shown in Figs. 3 and 4, it can be seen that the above-mentioned suspension of Ganoderma lucidum fruit body obtained by grinding the 〇3 face 钇 lead bead for just a minute is centrifuged for 1 〇 minutes to remove larger particles, and the supernatant is centrifuged. The particle size distribution of k is 28~578 nm (Fig. 3). The bulk of the body is about 105 nm, and 67% of the particles are less than 100 nm. It can increase its absorption in the body, centrifuge the supernatant, and save the private labor. The particles of the moon liquid are less than 1 μη!, although the solid content is low, but the active ingredient is extracted by grinding. All still retain 15 201036621 down ° and the particle size of the centrifugal drop is less than 1G_ (Figure 4), the texture is fine, can be used as a skin care product (such as mask) or dressing, artificial skin substrate and is rich in chitin and Cellulose' is therefore a good dietary fiber supplement. As shown in Fig. 5, the ground Ganoderma lucidum microparticles were observed microscopically, and the fresh Ganoderma lucidum fruiting bodies were carried by the blender and observed by scanning electron microscopy (SEM). The dendritic branches of the Ganoderma lucidum fruiting body were clearly visible from Fig. 5B. Road hyphae. After proper homogenization, the osteochords become more finely divided and loose (e.g., =5C), and their size is about tens to hundreds of micrometers, and this state will facilitate subsequent grinding treatment. Figure 5D shows the results of observation by a transmission electron microscope (TEM) after two-stage grinding. The circular particles in the figure are the nanoparticles in the suspension of the fruiting body of the spirit, which can be clearly seen from the pure The particles can reach the nanometer scale below μ1μιη, but the particle size range of the whole becomes larger due to the re-aggregation between the particles, which is up to several hundred nanometers, which is the sub-micron scale. This result also verified the results of the above particle size analyzer and reconfirmed that the medium grinding process used in the present invention can indeed reduce the Ganoderma lucidum particles after grinding of the Ganoderma lucidum fruit body to the nano/submicron scale. Since the Ganoderma lucidum fruiting body is rich in cellulose and the chitin texture is rough and firm, the particle size of these fibrous substances is lowered, and in addition to increasing the specific surface area, the taste of the product can be improved. The physiological effect of the fiber is related to the adsorption of the surface. Therefore, by increasing the specific surface area of the fiber, the physiological activity can be increased. The particle size of the dietary fiber is reduced from 〇1 to i (4). The specific surface area can be increased by 1 〇〇. The recommended intake of succumb fiber can be reduced to 1% of the original recommended amount. Below nm, it is recommended to take 16 201036621 to reduce it to one thousandth of the original recommended amount. In other words, by adding 50 to 500 ppm of nano/submicron dietary fiber to 500 mL of drinking water, the recommended daily intake of dietary fiber (25 g) is achieved. Based on this point of view, the centrifugation supernatant of the suspension of Ganoderma lucidum fruit body not only retains the physiological active ingredients unique to Ganoderma lucidum, but also provides a high surface area dietary fiber. (2) Relationship between grinding process and active ingredients

如表2所示,經介質研磨後,β-葡聚糖的含量明顯增加 ,以較大研磨介質(粒徑0.8 mm)進行研磨,產品中的β-葡聚糖含量與熱水萃取產品(約0.01 mg/mL )相近,隨著 介質粒徑的降低及研磨時間的增加,β-葡聚糖含量增加為熱 水萃取產品的4倍,且高於市面上所收集到的商品(0.0023 〜0.0202 mg/mL )。 表2As shown in Table 2, after the medium was ground, the content of β-glucan was significantly increased, and the grinding was carried out with a larger grinding medium (particle size 0.8 mm), and the content of β-glucan in the product was extracted with hot water ( About 0.01 mg/mL) is similar. As the particle size decreases and the grinding time increases, the β-glucan content increases four times that of hot water extraction products, and is higher than the products collected on the market (0.0023 ~ 0.0202 mg/mL). Table 2

測試樣品 β-葡聚糖含量(mg/mL) (β-l,3-D-glucan ) 熱水萃取 0.010±0.0 0.8 mm釔鍅珠研磨 0.0096+0.0004 0.3 mm紀錯珠研磨 0.0398±0·0003 Green (Amazon Biotechnology Co., Ltd) 0.0023 + 0.0001 Ex (Syngen Biotech Co., Ltd) 0·01±0.0001 Gene (Genefrem Biotechnology Co., Ltd) 0.02±0·0001 Natsuki (Hill-Top Food Co., Ltd) 0·0079±0.0001 Join-Yes (Join-Yes International Co., Ltd) 0·0025±0_0 各樣品皆進行三次取樣測試,三次平均值±SD 一般的市售商品,其聲稱之有效成分多以熱水或有機 溶劑來提取,雖可取得該有效成分,但提取量有限,且尚 有加工後之廢水、有機溶劑及殘渣處理問題。以機械式研 磨的製程方式,不但可使靈芝子實體懸浮液中具有纖維素 、幾丁質等膳食纖維,亦可藉由細磨過程中靈芝子實體細 17 201036621 胞壁的破碎,促使有效成份的釋出。 如表3所不,幾丁質含量亦有類似的現象以 介質研磨所得之產品中幾丁f含量· _ 嬸猓的太〇 门、υ·δ mm介質研磨所 獲于的產。。,但若以離心方式將所得產品中 移除後,上清液之幾丁質含|目,丨士 尺的顆拉 教幅下降,但仍約為一般 …7 料產品的5倍,可見該被移除之顆粒含有幽含 的幾丁質。由於熱水提取幾乎只可抽得水溶性㈣,3 提取液中之幾丁質含量甚低,絕大部分都殘存在藥潰中。、 含有35〜40%幾丁質,4〇〜50%卜葡聚糖其餘為以 ',,、色素(―為主之含氮物,為良好的膳食纖維來 源,如將子實體粉碎並細磨至奈米/次微米尺寸不僅可取 代萃取’產品中亦將保存子實體的所有成分(富含幾丁質 、纖維素等腊食纖維),且因粒子小,有助於人體的吸收, 所以此奈米/次《級靈芝子㈣懸浮液或其濃縮產品將適 於作為保健食品之添加物Test sample β-glucan content (mg/mL) (β-l,3-D-glucan) Hot water extraction 0.010±0.0 0.8 mm bead grinding 0.0096+0.0004 0.3 mm Jiuzhu beads grinding 0.0398±0·0003 Green (Amazon Biotechnology Co., Ltd) 0.0023 + 0.0001 Ex (Syngen Biotech Co., Ltd) 0·01±0.0001 Gene (Genefrem Biotechnology Co., Ltd) 0.02±0·0001 Natsuki (Hill-Top Food Co., Ltd )·········· The hot water or organic solvent is extracted, although the active ingredient can be obtained, but the extraction amount is limited, and there are still problems in the treatment of wastewater, organic solvent and residue after processing. In the mechanical grinding process, not only the dietary fiber such as cellulose and chitin can be obtained in the suspension of Ganoderma lucidum fruit body, but also the active ingredient can be broken by the crushing of the cell wall of the Ganoderma lucidum fruit body during the fine grinding process. Released. As shown in Table 3, there is a similar phenomenon in the chitin content. The product obtained by grinding the medium obtained by the medium grinding is obtained from the grinding of the Taihaomen, υ·δ mm medium. . However, if the obtained product is removed by centrifugation, the chitin of the supernatant contains the mesh, and the width of the gentleman's ruler is reduced, but it is still about 5 times that of the general ... 7 product. The removed particles contain a cryptic chitin. Since the hot water extraction can only extract water solubility (4), the content of chitin in the 3 extracts is very low, and most of them are left in the medicine. Containing 35~40% chitin, 4〇~50% glucan, the rest is ',,, pigment (mainly nitrogenous, good source of dietary fiber, such as crushing and thinning fruiting bodies) Grinding to nano/sub-micron size can not only replace the extraction 'products will also preserve all the components of the fruiting body (rich in chitin, cellulose and other wax fiber), and because of the small particles, it helps the body to absorb, Therefore, this nano/second "Shenzhizhizi (4) suspension or its concentrated product will be suitable as an additive for health foods.

-- (二)靈芝子實體懸浮液之穩定性 如圖6〜8所示,靈芝子實體經研磨後,高濃度的靈芝 微粒及寬廣的粒徑分佈,促使靈芝微粒間相互碰撞並迅速 聚集成較大之微粒團簇,粒徑的增加致使重力效應遠大於 18 201036621 布朗運動效應,進而產生明顯的沉降現象。於4它下靜置 24小時後分析其粒徑,微粒已聚集並形成數十微米之圏鎮 ’體積平均粒徑增至9·35 μιη (如圖6所示),考量研磨產品於 後續加工,如冷康貯藏、冷;東乾燥或高溫滅菌加工等之安 定性,針對冷来(俄,24 +時)及高壓蒸汽滅g ( 12H 15分鐘)後之子實體懸浮液進行粒徑分析以探討 加工前後之粒徑分佈差異。 S芝子實體懸浮液之靈芝微粒於冷; 東過程中會再聚集 ’解;東後似有離水之相分離現象,聚集形成的微粒團箱呈 棉絮狀並難以物理或機械力(如震盪、均質、超音波震盪 4理)將之分散,冷;東後子實體懸浮液之粒徑分佈如圖7 ,體積平均粒徑為109 μηι。高麼蒸汽滅菌處理亦會造成微 粒間嚴重的再聚集作用,形成呈團塊狀之微粒團藏,並如 同冷束處理般難以物理或機械力將之分散,其粒徑分佈範 圍5.9〜824.5 _,體積平均粒徑為132 _ (如圖8所示)。機 〇 $式研磨所得之靈芝子實體懸浮液,粒#分佈範圍寬廣, 易再聚集沉澱,但固形物含量高,富含幾丁質、纖維素, 此靈芝子實體懸浮液或其濃縮產品將適於作為保健食品之 添加物。 (四)靈芝子實體懸浮液之離心上清液的穩定性 如表4所示,研磨時間的改變,除了會影響靈芝微粒 平均粒徑外,也間接影響儲存安定性,研磨時間越長者, 產品的穩定性越高。研磨3G分鐘之$芝子實體懸浮液的離 心上清液產品(1〇_g離心10分鐘),經21天的儲存體積 19 201036621 平句粒彳二由0 195增加為】199 μπι,但研磨i8〇分鐘之靈芝 、,實體w浮液的上清液產品(丨〇〇〇〇g離心1 〇分鐘),體積 平均粒徑由G.126增為〇.137 μηι,增加率低於1()%,顯示增 加研磨時間有助於粒子的穩定性-- (2) The stability of the suspension of Ganoderma lucidum fruit body is shown in Figure 6~8. After the grinding of the Ganoderma lucidum fruiting body, the high concentration of Ganoderma lucidum particles and the broad particle size distribution promote the collision and rapid integration of Ganoderma lucidum particles. Larger particle clusters, the increase in particle size causes the gravity effect to be much greater than the Brownian motion effect of 18 201036621, which in turn produces significant sedimentation. After 4 hours of standing under it for 24 hours, the particle size was analyzed, and the particles were aggregated and formed into tens of micrometers. The volume average particle size increased to 9.35 μιη (as shown in Fig. 6), and the abrasive product was considered for subsequent processing. For example, the stability of cold storage, cold, east drying or high temperature sterilization, etc., for the particle size analysis of the fruiting body suspension after cold (Russian, 24 +) and high pressure steam elimination g (12H 15 minutes) The difference in particle size distribution before and after processing. The Ganoderma lucidum particles in the S-substantial suspension are cold; in the east process, they will accumulate 'solution; the east will appear to be separated from the water. The clusters formed by the aggregation are cotton-like and difficult to physically or mechanically (such as shock, Homogenization, ultrasonic vibration 4)) Disperse, cold; the particle size distribution of the East Sub-submerged suspension is shown in Figure 7, the volume average particle size is 109 μηι. High steam sterilization also causes severe re-aggregation between the particles, forming a mass of clusters of particles, and it is difficult to disperse it like physical or mechanical force as cold beam treatment, and its particle size distribution range is 5.9~824.5 _ The volume average particle size is 132 _ (as shown in Figure 8). The suspension of the Ganoderma lucidum fruit body obtained by the machine grinding method has a wide distribution range and is easy to accumulate and precipitate, but the solid content is high, and it is rich in chitin and cellulose. The suspension of the Ganoderma lucidum fruit body or its concentrated product will be Suitable as an additive to health foods. (4) The stability of the centrifugation supernatant of the suspension of Ganoderma lucidum fruit body is shown in Table 4. The change of grinding time, in addition to affecting the average particle size of Ganoderma lucidum particles, also indirectly affects the storage stability, the longer the grinding time, the product The higher the stability. Grinding the centrifugation supernatant product of the 3 G min of the Shiba solid suspension (1 〇g for 10 minutes), after 21 days of storage volume 19 201036621, the flat granules were increased from 0 195 to 199 μπι, but grinded I8 min of Ganoderma lucidum, the supernatant product of the solid w float (centrifugation for 1 〇 minutes), the volume average particle size increased from G.126 to 〇.137 μηι, the increase rate is less than 1 ( %), showing increased grinding time helps particle stability

研磨時間 (分鐘) 30 體積平均粒徑(β m ) volume mean diameter) 0.195 0.158 數量平均粒徑(以m ) X number mean diameter ) 0.127 90 0.341 ,0.092 0.078 研麼 30〜---—~~~~~~~° 0 068 ^ 8_⑽珠進行之第-階段研磨結果。 -~釔锆珠進行ϋ二階段研磨結果 0.064 接著,就凍乾、高壓蒸汽滅菌及濃縮處理對靈芝子實 體懸浮液之離心上清液的影響做一探討。 如圖9所示,先將靈芝上清液經凍乾後,再分散於水 溶液中,並以Nanotrac 150粒徑分析儀測定粒徑分佈(粒 «測上限為6·54 μη〇 ’由結果可知東乾處理會促使靈 芝微粒間再聚|。床乾後,粒徑分佈冑圍寬$,有相當比 例微粒之粒徑大於6.54 μιη (礙於儀器量測上限而無法測得 )’其體積平均粒徑為1.177 μιη。 如圖10a所示,離心上清液經高壓蒸汽滅菌處理後仍保 有相當好的安定性,滅菌處理後,待溫度下降至室溫即量 測其粒徑,所有粒子皆小於i μηι,粒徑分佈範圍36〜8〇ζ ⑽,體積平均粒徑為140nm,且仍有鄕的微粒維持在 100 nm以下。觀察其於室溫下貯存28天(如圖i〇b所示) 20 201036621 (如圖10e所示)之粒徑變化’粒徑分佈雖有往大粒 工’但偏移幅度甚小,而其體積平均粒徑亦只分別增 —65 nm和373 nm,顯示離心上清液經高溫作用後仍十分 穩定’粒子於貯存期間之再聚集現象並不顯著。 、藉由離心雖可將離心上清液之粒捏分佈降至^阿以下 並使其具有較佳之穩定性,但相對的離心上清液之固 形物3量及靈芝微粒數則大幅減少。為提高固形物濃度, 以減壓濃縮方式降低離心上清液之水分含量,並於不同濃 縮倍率(C〇ncentration rati〇)下取樣,量測其粒徑變化。濃 縮倍率之„十算疋以原液體積除上最終濃縮液體積。冑u與 表5為離心、上清液經2、4、8、12及2G倍濃縮後之粒徑分 析釔果,低於4倍濃縮之離心上清液,其粒徑變化不大, 體積平均粒徑只增加33%,且微粒皆小於i μιη。濃縮8倍 以上時’粒子間開始有聚集現象產生並使粒徑分佈往大 粒徑偏移,粒徑分佈大於1 μηι。就本實施例而言,為提高 產σΰ固形物漢度並兼顧安定性,將離心上清液濃縮4〜6倍 應可符合所需。 21 201036621 表5 上清液濃縮倍率 (濃度) 體積平均粒徑 (U m) 粒徑分布範圍 (u m) 粒徑小於 1 U m之微粒含晋(Ό/λ 0 (3.4 mp/mi ^ 0.105 0.03-0.578 100 2 (6.8 mp/mi > 0.141 0.036 〜0.750 100 4 —mp/mL) 0.140 0.030-0.972 100 8 0.351 0.033 〜2.120 95 12 -X40.8 mp/mi ) 1.922 0 · 111 〜6.54 61 20 -J68.0 rnff/ηιΐΛ 1.880 0.859 〜6.54 61 (五)乳化劑對靈芝子實體懸浮液穩定性之影響 濁度是一量測簡易之物理參數,對穩定分散之懸浮溶 液而言,其濁度不應隨時間而呈現顯著差異。因此,本發 明針對所欲探討的各種變因,進行濁度分析,以筛選較佳 的乳化劑。 如表6所示,未添加乳化劑之靈芝子實體經研磨後, 靈芝子實體懸浮液濁度高於1000 Ντυ,稀釋2、5、1〇和 50倍後之試樣的濁度均隨時間而逐漸下降,稀釋倍率愈高 ^蜀度之變化率愈小。低濃度(高稀釋倍率)懸浮液之濁度^ 疋性較高濃度(低稀釋倍率)佳,顯示微粒濃度是影響懸浮液 穩疋性的重要參數,濃度愈高微粒間碰撞機率愈高,聚集 現象也相對明顯。整體而言,微粒間的聚集相當明顯,致 使靈芝子實體懸浮液的聚集沉降行為明顯。 22 201036621Grinding time (minutes) 30 volume average particle size (β m ) volume mean diameter) 0.195 0.158 number average particle size (in m) X number mean diameter ) 0.127 90 0.341 , 0.092 0.078 research 30~----~~~ ~~~~° 0 068 ^ 8_(10) The first stage grinding results of the beads. -~钇Zirconium beads for the second stage grinding result 0.064 Next, the effects of lyophilization, autoclaving and concentration treatment on the centrifugation supernatant of the body suspension of Ganoderma lucidum were discussed. As shown in Fig. 9, the supernatant of Ganoderma lucidum was lyophilized, then dispersed in an aqueous solution, and the particle size distribution was measured by a Nanotrac 150 particle size analyzer (the upper limit of the particle measurement was 6.54 μη〇). Donggan treatment will promote the re-polymerization of Ganoderma lucidum particles. After the bed is dry, the particle size distribution is wider than $, and a certain proportion of the particles have a particle size larger than 6.54 μιη (which cannot be measured due to the upper limit of the instrument measurement). The particle size is 1.177 μηη. As shown in Figure 10a, the centrifuged supernatant retains a fairly good stability after autoclaving. After sterilization, the particle size is measured after the temperature drops to room temperature. Less than i μηι, the particle size distribution range is 36~8〇ζ (10), the volume average particle size is 140nm, and the ruthenium particles remain below 100 nm. It is observed to be stored at room temperature for 28 days (as shown in Figure i〇b) Show) 20 201036621 (as shown in Figure 10e) The particle size change 'particle size distribution has a large particle size' but the offset is very small, and its volume average particle size is only increased by -65 nm and 373 nm, respectively. Centrifugal supernatant is still very stable after high temperature action The re-aggregation phenomenon during the storage period is not significant. By centrifugation, the centrifugation distribution of the centrifugation supernatant can be reduced to below and the stability is stabilized, but the relative centrifugation supernatant solids 3 The amount of Ganoderma lucidum particles was greatly reduced. In order to increase the concentration of solids, the water content of the supernatant was reduced by concentration under reduced pressure, and the particle size was measured under different concentration ratios (C〇ncentration rati〇). The concentration ratio is divided into the volume of the final concentrate by the volume of the original solution. 胄u and Table 5 are the particle size analysis results after centrifugation and concentration of the supernatant by 2, 4, 8, 12 and 2G times. In the concentrated supernatant of 4 times concentrated, the particle size did not change much, the volume average particle size only increased by 33%, and the particles were all smaller than i μιη. When the concentration was more than 8 times, the aggregation between the particles began to occur and the particle size was generated. The distribution is shifted to a large particle size, and the particle size distribution is greater than 1 μηι. In the present embodiment, in order to improve the σ ΰ solid content and balance stability, the centrifugation supernatant is concentrated 4 to 6 times to meet the requirements. 21 201036621 Table 5 Concentration ratio of supernatant (concentrated Volume average particle size (U m) Particle size distribution range (um) Particles with a particle size of less than 1 U m contain Jin (Ό/λ 0 (3.4 mp/mi ^ 0.105 0.03-0.578 100 2 (6.8 mp/mi > 0.141 0.036 ~0.750 100 4 —mp/mL) 0.140 0.030-0.972 100 8 0.351 0.033 ~2.120 95 12 -X40.8 mp/mi ) 1.922 0 · 111 ~6.54 61 20 -J68.0 rnff/ηιΐΛ 1.880 0.859 ~6.54 61 (5) Effect of emulsifier on the stability of suspension of Ganoderma lucidum fruit body The turbidity is a simple physical parameter. For a stable dispersion of suspended solution, the turbidity should not be significantly different with time. Accordingly, the present invention performs turbidity analysis for various variables to be explored to screen for preferred emulsifiers. As shown in Table 6, the turbidity of the Ganoderma lucidum fruit body suspension after grinding without adding an emulsifier is higher than 1000 Ντυ, and the turbidity of the samples after dilution of 2, 5, 1 〇 and 50 times is over time. Gradually, the higher the dilution ratio, the smaller the rate of change. Low concentration (high dilution ratio) suspension turbidity ^ high concentration (low dilution ratio), showing that the particle concentration is an important parameter affecting the stability of the suspension. The higher the concentration, the higher the collision probability between particles. The phenomenon is also relatively obvious. On the whole, the aggregation between the particles is quite obvious, and the aggregation and sedimentation behavior of the suspension of the Ganoderma lucidum fruit body is obvious. 22 201036621

靜置時間 ------ 濁度(NTU) (小時) DF = 〇 2 5 10 50 0 ΝΑ 575 230 107 20.1 1/4 ΝΑ 582 215 105 20 1 1/2 ΝΑ 595 209 103 19 7 1 ΝΑ 617 204 102 19 7 2 ΝΑ 718 25.6 101 19 5 4 ΝΑ ΝΑ 22.0 40.8 19 5 8 ΝΑ 27.8 20.3 21.4 1 0 1 24 ΝΑ 28.7 ~~ 21.7 18.3 i 7 J 20 〇 48 ΝΑ 30.3 17.6 13.7 17 8 72 ΝΑ 38.3 16.7 13.1 1 Λ Λ 96 831 36.3 14.2 11.2 1 Ί A :稀釋比率 -- 丄 4 · VJResting time ------ turbidity (NTU) (hours) DF = 〇2 5 10 50 0 ΝΑ 575 230 107 20.1 1/4 ΝΑ 582 215 105 20 1 1/2 ΝΑ 595 209 103 19 7 1 ΝΑ 617 204 102 19 7 2 ΝΑ 718 25.6 101 19 5 4 ΝΑ ΝΑ 22.0 40.8 19 5 8 ΝΑ 27.8 20.3 21.4 1 0 1 24 ΝΑ 28.7 ~~ 21.7 18.3 i 7 J 20 〇48 ΝΑ 30.3 17.6 13.7 17 8 72 ΝΑ 38.3 16.7 13.1 1 Λ Λ 96 831 36.3 14.2 11.2 1 Ί A : dilution ratio -- 丄 4 · VJ

ΝΑ : >1000NTU 於本發明中,選擇以不同HLB(hydr〇phile_lip〇phile balance,親水親脂均衡)之蔗糖醋(sugar “〖π,hlb分別 為3、7、11和1S)、聚山梨醇酐脂肪酸酯(外时85、8〇、 6〇、2〇 和 丁赠11 65、20,HLB 分別為 1>8、4_3、6 7、8 6 、1〇_6和16.7)及脂肪酸甘油脂(HLB為3 8)作為初步筛 選的乳化齊J,添加量先固定為相對於靈芝子實體重量之5 %ΝΑ : >1000NTU In the present invention, sucrose vinegar (sugar "〖π, hlb respectively 3, 7, 11 and 1S), poly sorbitol, which is different in HLB (hydrophile phile_lip phile balance) Alcoholic fatty acid esters (85, 8〇, 6〇, 2〇 and Ding gift 11 65, 20, HLB 1 > 8, 4_3, 6 7 , 8 6 , 1〇_6 and 16.7, respectively) and fatty acids Glycerolipid (HLB is 38) as the initial screening of the emulsification J, the amount of addition is first fixed to 5% of the weight of the Ganoderma lucidum fruiting body

如圖12 14所示,分別為靈芝子實體懸浮液稀釋倍率$ 倍、H)倍和50倍下,濁度變化率隨時間之關係。濁度變化 率為負值表示濁度下降,正值則表示上升。除了少數的正 值外,幾乎所有試驗的濁度變化趨勢均為下降。 整體而言,稀釋倍率愈高,微粒間碰撞機率降低,聚 集作用減緩,濁度隨時間的變化率趨緩,各稀釋倍率的濁 度均隨時間的增加而下降。 ppm 在最高稀釋㈣50的情況下(靈芝微粒濃度約 23 201036621 (01 mg/mL) )蜀度變化率最+,且以聚山梨醇酐脂肪 酸S曰類礼化劑的穩疋性較佳,於%小時後濁度變化率絕對 值均小於3 0 %。於低絲摇办士 低稀釋倍率(5倍及10倍)下,濁度變 化率與乳化劑種類、HLB值似無關聯性,%小時後濁度變 化率絕對值均大於8〇%’即無顯著穩定效果。 因此如以濁度作為判斷基準,京尤靈芝子實體懸浮液 而°以5 /(>添加量之聚山梨醇酐脂肪酸酯作為分散劑,對 濃度100 ppm (最尚稀釋倍率5〇倍)之靈芝子實體懸浮液 有較佳的穩定性。 由表7之粒徑(靈芝微粒濃度為l〇〇 ppm)分析結果可 知未添加礼化劑之靈芝子實體懸浮液經靜置存放96小時 後’靈之微粒再聚集後的體積平均粒徑(MV)為3 24叫 ,其中,粒徑小於1 μηι的微粒(奈米/次微米級)佔靈芝子 實體總質量的24.9%,粒徑屬奈米尺度(小於_ nm)者 則佔靈芝子實體總質量❸2 〇4%。於研磨時添加5%乳化劑 時,添加脂肪酸甘油脂、Span 85及Span 8〇者之體積平均 粒徑變化幅度較小’分別變為3.86、2.90、3.68 μΐη。另外 提同界面電位值將有助於微粒之穩定性,靈芝子實體懸 浮液未添加乳化劑之界面電位值約_丨丨7 ,本實施例所使 用乳化劑中,以Span 85、Span 80及Span 20對於微粒界面 電位的增加較為顯著,界面電位值分別為-16.7、-13.8及-13·7 mV。 知合上述濁度分析、粒徑分析和介面電位分析結果, 於乳化劑添加量5%的情況下,HLB值小的乳化劑有助於穩 24 201036621 定靈芝子實體懸浮液系統,因此,選擇薦糖醋(hlb 3)、 脂肪酸甘油脂(HLB 3.8)、Span 85 (HLB丨8)及邡抓8〇 (HLB 4.3)等,進行乳化劑添加量對$芝子實體懸浮液系 統穩定性影響之測試。As shown in Fig. 12, respectively, the turbidity change rate is related to time under the diluting magnifications of Ganoderma lucidum fruit body suspensions of $, H) and 50 times, respectively. A turbidity change rate of negative values indicates a decrease in turbidity, and a positive value indicates an increase. With the exception of a few positive values, the turbidity trend of almost all tests was reduced. On the whole, the higher the dilution ratio, the lower the collision probability between particles, the slower the aggregation effect, the slower the change rate of turbidity with time, and the turbidity of each dilution ratio decreased with time. Ppm In the case of the highest dilution (four) 50 (Ganoderma lucidum particle concentration about 23 201036621 (01 mg / mL)), the rate of change of the most is +, and the stability of the polysorbate fatty acid S 曰 ritual agent is better, The absolute value of the change rate of turbidity after % hour is less than 30%. Under the low dilution ratio (5 times and 10 times) of the low-silk shaker, the turbidity change rate is not related to the emulsifier type and HLB value, and the absolute value of the turbidity change rate after % hour is greater than 8〇%. No significant stability effect. Therefore, if the turbidity is used as a criterion, the Jingyou Ganoderma lucidum fruit body suspension is 5/(> added amount of polysorbate fatty acid ester as a dispersing agent, and the concentration is 100 ppm (the most suitable dilution ratio is 5 times). The suspension of Ganoderma lucidum fruit body has better stability. From the analysis of the particle size of Table 7 (the concentration of Ganoderma lucidum microparticles is 1〇〇ppm), it can be seen that the suspension of Ganoderma lucidum fruit body without adding ritual agent is stored for 96 hours. The volume average particle size (MV) of the post-aggregation particles is 3 24, wherein the particles having a particle size of less than 1 μη (nano/submicron) account for 24.9% of the total mass of the Ganoderma lucidum fruit body. On the nanometer scale (less than _ nm), the total mass of Ganoderma lucidum fruit body is ❸2 〇 4%. When 5% emulsifier is added during grinding, the volume average particle size of fatty acid glyceride, Span 85 and Span 8 添加 is changed. The smaller amplitudes are 3.86, 2.90, 3.68 μΐη respectively. In addition, the interface potential value will contribute to the stability of the particles, and the interface potential value of the ginseng fruit body suspension without adding emulsifier is about _丨丨7. Examples of emulsifiers used, with Span 85 and Span 80 And Span 20 has a significant increase in the interfacial potential of the particles, and the interface potential values are -16.7, -13.8, and -13·7 mV, respectively. The above turbidity analysis, particle size analysis, and interface potential analysis results, the amount of emulsifier added. In 5% of cases, an emulsifier with a small HLB value helps to stabilize the suspension system of Ganoderma lucidum fruit body. Therefore, it is recommended to recommend sweet and sour vinegar (hlb 3), fatty acid glyceride (HLB 3.8), and Span 85 (HLB丨). 8) and 邡 8〇 (HLB 4.3), etc., the test of the effect of the amount of emulsifier added on the stability of the liquid storage system of the sage.

^如表8、9所示,靈芝子實體懸浮液於不同乳化劑添加 置(相對於靈芝子實體重量之5%、10%、20%和50%)時^ As shown in Tables 8 and 9, when the suspension of Ganoderma lucidum fruit body is added to different emulsifiers (relative to 5%, 10%, 20% and 50% of the weight of Ganoderma lucidum fruiting body)

之粒彳二刀析、界面電位量測結果。由粒徑分佈結果可知, 四種乳化劑中以Span 8G之穩定效果較佳其添加量薦時 可將微粒之體積平均粒徑降至2.29 μιη,並提高奈米和次 、米粒子所佔的比例。觀察界面電位之變化情形可發現, 提同四種乳化劑的添加量皆可增加靈芝子實體懸浮液之界 面電位值,但高於20%則穩定效果有限。 25 201036621 厂 表8 乳化劑種類 乳化劑 添加量(%) 體積平均 粒徑(μηι) 數量平均 粒徑(μηι) 奈米粒子 含量(wt%) 奈米/次微 米粒子含量 Γλ»/會 、 無乳化劑 0 3.43±〇.2S 0.121 2.04 24 Q 蔗糖酯(HLB 3) 5 !〇·5±〇.16 0.106 1.99 1 ο A 脂肪酸甘油脂 (HLB 3.8) __5 10 3-91+0.05 5-94 + 0.36 0.107 2.73 1 二.0 17.2 0.116 2.85 26 3 20 9.06+0.56 0.102 2.91 1 ς £ Span 8 5 (HLB 1.8) —5 2.95±〇.ftfi 0.111 2.61 20.1 2.55 + 0.07 0.139 1.66 33.7 20 2.48±〇.〇7 Γ 0.172 0.67 20 A Span 80 (HLB 4.3) 5 3.78±0.14 0.108 3.11 21 8 10 Γ2.29 + 0.14 0.126 3.03 40 6 20 3.51+0.11 0.138 1.93 34.3 表9 乳化劑種類 界面電位(zeta potential) 5% 10% 20% 50% 蔗糖酯(HLB 3) -11.5±1.0 -12.910.2 -14.2 + 0.8 脂肪酸甘油脂 (HLB 3.8) ·10_7±0·4 -13.810.3 16.6+1.1 Span 85(HLB 1.8) -15.7+0.9 -16.3 + 0.6 -21.2 + 0.8 -2 S 3 + 1 7 Span 80(HLB 4.3) -13.8±0·5 -14.1+0.4 -24.2±l_〇 -24.7 + 1 .〇 在28天亞急毒性試驗期間,雄、雌性小鼠對照組及處 理組之平均每日體重變化、平均每曰食物消耗量與平均每 曰水消耗®皆無顯著差異,雄、雌性小鼠處理組和對照組 血液分析亦無明顯差異’其檢測值皆在正常值範圍内,主 要器官之組織切片檢查亦正常,所以在試驗期間並未造成 死亡現象以及引發不良臨床徵兆。 综觀上述’靈芝子實體含有大量粗纖維及木質素成分 ’且一般真菌細胞壁的成分除了纖維素外尚有幾丁質,如 靈芝多醣等活性成分亦多存在於細胞壁中,本發明透過機 械式研磨來製造靈芝子實體懸浮液的方式,除了無項萃取 26 201036621 即可獲得完整的活性成分外,還可大幅提高纖維質比表面 積,且纖維質之後續利用無須再粉碎,可作為一良好的腾 食纖維添加物。其中,研磨所得之靈芝子實體懸浮液再經 後續離心處理後,離心沉降物中富含幾丁質及纖維素,其 顆粒尺寸小於Η)叫,質地細緻,可作為保養品(如面膜) 或敷料Λ工皮膚之基材,而離心上清液中,靈芝微粒粒 徑皆屬奈米/次微米級,並保有完整之活性成份,其幾丁質 0 冑有效成分為傳統熱水萃取之5倍以上,且含有部分粒徑 車交小之纖維素’同樣可用以作為保健食品之添加物,故確 實能達成本發明之目的。 ' ㈣上所述者,僅為本發明之較佳實施例而已,當不 旎以此限疋本發明實施之範圍,即大凡依本發明申請專利 軌圍及發明說明内容所作之簡單的等效變化與修飾,皆仍 屬本發明專利涵蓋之範圍内。 【圖式簡單說明】 〇 ® 1是體積平均粒徑相對研磨轉速與進料濃度之曲線 圖; ' 圖2疋研磨時間相對粒徑之曲線圖; 圖疋靈乏子實體懸浮液之離心上清液的粒徑分布圖 贅 • 圖4疋靈芝子實體懸浮液之離心沉澱物的粒徑分布圖 > 圖5是靈芝子實體之影像圖;說明靈芝子實體自尚未 研磨至經過機械式研磨後之粒徑變化; 27 201036621 圖6是靈芝子實體懸浮液於代儲存後之粒徑分布圖; 圖7是靈芝子實體懸浮液經過冷束乾燥後之粒徑分布 圖; 圖8是靈芝子實體懸浮液經過高壓蒸氣滅菌後之粒後 分布圖; 圖9是靈芝子實體懸浮液之離心上清液經冷凍處理後 的粒徑分布圖; 圖1〇是靈芝子實體懸浮液之離心上清液經高壓蒸氣滅 菌後之不同儲存時間的粒徑分布圖; 圖11是靈芝子實體懸浮液之離心上清液經濃縮後的粒 徑分布圖; 圖12是靈芝子實體與乳化劑一起經機械式研磨後,靈 芝子實體懸浮液之濁度變化曲線圖; 圖13是靈芝子實體與乳化劑一起經機械式研磨後,靈 芝子實體懸浮液之濁度變化曲線圖;及 圖14是靈芝子實體與乳化劑一起經機械式研磨後,靈 芝子實體懸浮液之濁度變化曲線圖。 28 201036621 【主要元件符號說明】 無The particle 彳 two knife analysis, interface potential measurement results. From the results of particle size distribution, it is known that the stability of Span 8G is better among the four emulsifiers. The addition amount of the emulsifier can reduce the volume average particle size of the particles to 2.29 μηη, and increase the content of nanoparticles and sub- and m-particles. proportion. Observing the change of the interface potential, it can be found that the addition of the four emulsifiers can increase the interface potential of the suspension of Ganoderma lucidum fruit body, but the stability effect is limited when it is higher than 20%. 25 201036621 Factory Table 8 Emulsifier Type Emulsifier Addition (%) Volume Average Particle Size (μηι) Quantity Average Particle Size (μηι) Nanoparticle Content (wt%) Nano/Submicron Particle Content Γλ»/会,无Emulsifier 0 3.43±〇.2S 0.121 2.04 24 Q Sucrose ester (HLB 3) 5 !〇·5±〇.16 0.106 1.99 1 ο A fatty acid glyceride (HLB 3.8) __5 10 3-91+0.05 5-94 + 0.36 0.107 2.73 1 2.0 17.2 0.116 2.85 26 3 20 9.06+0.56 0.102 2.91 1 ς £ Span 8 5 (HLB 1.8) —5 2.95±〇.ftfi 0.111 2.61 20.1 2.55 + 0.07 0.139 1.66 33.7 20 2.48±〇.〇 7 Γ 0.172 0.67 20 A Span 80 (HLB 4.3) 5 3.78±0.14 0.108 3.11 21 8 10 Γ2.29 + 0.14 0.126 3.03 40 6 20 3.51+0.11 0.138 1.93 34.3 Table 9 Emulsifier type interface potential (zeta potential) 5% 10% 20% 50% sucrose ester (HLB 3) -11.5±1.0 -12.910.2 -14.2 + 0.8 fatty acid glycerides (HLB 3.8) ·10_7±0·4 -13.810.3 16.6+1.1 Span 85 (HLB 1.8) -15.7+0.9 -16.3 + 0.6 -21.2 + 0.8 -2 S 3 + 1 7 Span 80(HLB 4.3) -13.8±0·5 -14.1+0.4 -24.2±l_〇-24.7 + 1 .〇28 days Asian emergency During the toxicity test, there was no significant difference in mean daily body weight change, average food consumption per meal, and average water consumption per liter of water in male and female control groups, and blood analysis in male and female mice treated and control groups. There was no significant difference. The detection values were all within the normal range, and the biopsy of the main organs was normal. Therefore, no deaths were caused during the trial and adverse clinical signs were caused. The above-mentioned 'Ganoderma lucidum fruiting body contains a large amount of crude fiber and lignin component' and generally the components of the fungal cell wall are chitinous in addition to cellulose. Active ingredients such as Ganoderma lucidum polysaccharide are also present in the cell wall, and the present invention is mechanically Grinding to make the suspension of Ganoderma lucidum fruit body, in addition to the no-extraction extraction 26 201036621 can obtain the complete active ingredients, can also greatly increase the specific surface area of the fiber, and the subsequent use of the fiber does not need to be crushed, can be used as a good Take advantage of fiber additives. Wherein, the ground suspension of the Ganoderma lucidum fruit body obtained by grinding is subjected to subsequent centrifugation, and the centrifugation sediment is rich in chitin and cellulose, and the particle size is smaller than Η), the texture is fine, and can be used as a skin care product (such as a mask) or The dressing is applied to the substrate of the skin, and in the centrifugation supernatant, the particle size of the ganoderma lucidum particles is nanometer/submicron, and the intact active ingredient is retained, and the chitin 0 胄 active ingredient is the traditional hot water extraction 5 More than a multiple, and a cellulose having a partial particle size is also available as an additive to health foods, and the object of the present invention can be achieved. The above is only the preferred embodiment of the present invention, and is not limited to the scope of the present invention, that is, the simple equivalent of the patent application and the description of the invention according to the present invention. Variations and modifications are still within the scope of the invention. [Simple description of the diagram] 〇® 1 is a graph of volume average particle size versus grinding speed and feed concentration; 'Fig. 2 曲线 grinding time relative particle size curve; 疋 疋 疋 子 子 体 体Figure 2 shows the particle size distribution of the centrifuged sediments of the Ganoderma lucidum fruiting body suspension. Figure 5 is an image of the Ganoderma lucidum fruiting body; it shows that the Ganoderma lucidum fruiting body has not been ground until after mechanical grinding. Particle size change; 27 201036621 Figure 6 is the particle size distribution of the suspension of Ganoderma lucidum fruit body after storage; Figure 7 is the particle size distribution of the suspension of Ganoderma lucidum fruit body after cold beam drying; Figure 8 is the Ganoderma lucidum fruiting body The post-granulation distribution of the suspension after autoclaving; Figure 9 is the particle size distribution of the centrifuged supernatant of the suspension of Ganoderma lucidum fruit body after freezing; Figure 1 is the centrifugation supernatant of the suspension of Ganoderma lucidum fruiting body Figure 9 shows the particle size distribution of the centrifuged supernatant of the suspension of Ganoderma lucidum fruit body after concentration; Figure 12 shows the particle size distribution of the supernatant of the suspension of Ganoderma lucidum fruit body; Turbidity curve of the suspension of Ganoderma lucidum fruit body after mechanical grinding; Figure 13 is a graph showing the turbidity of the suspension of Ganoderma lucidum fruit body after mechanical grinding of Ganoderma lucidum fruit body together with emulsifier; The turbidity curve of the suspension of Ganoderma lucidum fruit body after mechanically grinding together with the emulsifier. 28 201036621 [Explanation of main component symbols]

2929

Claims (1)

201036621 七 、申請專利範圍: L 一種靈芝子實體懸浮液, 始抓π , 马靈之子實體經由機械式研磨 後所侍到含有靈芝微粒之 維質、幾丁質,及β_”糖 徑小於丨。_。 且靈芝微粒之體積平均粒 ^據^專利範圍第1項所述之靈芝子實體懸浮液,其 广、到、於1 μΐΏ之靈芝微粒佔靈芝總質量的1〇%以 3. 依據申請專利範圍第2 中,幾丁質含量高於〇. 4. 項所述之靈芝子實體懸浮液,其 mg/mL。 5. 6. 依據申請專利範圍第3 中’纖維質含量高於〇. 依據申請專利範圍第4 中’ 葡聚糖含量高於 依據申請專利範圍第j 液,還包含一與靈芝子 性乳化劑。 項所述之靈芝子實體懸浮液,其 1 mg/mL。 項所述之靈芝子實體懸浮液,其 〇.〇1 mg/mL。 、2或5項所述之靈芝子實體懸浮 實體一起進行機械式研磨之可食 7. 依據申請專利範圍第 中,該可食性乳化劑是所述之靈之子實㈣浮液,其 該可食性乳化劑含量是卜自於非離子型界面活性劑,且 8. 依據申請專利範圍第7 <子實體重量的0.1〜25%。 其 中,該可食性乳化劑之^所述之靈之子實體懸浮液 9. 依據f請專利範圍帛8 ^值”於1〜18。 其 中,可食性乳化劑之m斤述之靈芝子實體懸浮液 值介於1〜1〇。 30 201036621 10·依據申請專利範圍第9項所述之靈芝子實體懸浮液,其 中,可食性乳化劑之HLB值介於1〜5。 11. 依據申請專利範圍第10項所述之靈芝子實體懸浮液,其 中,該可食性乳化劑是選自於由薇糖脂、聚山梨醇酐脂 肪酸脂、脂肪酸甘油脂’以及藉、糖脂、聚山梨醇奸脂肪 酸脂、脂肪酸甘油脂之混合所組成之群體。 12. 依據申請專利範圍第u項所述之靈芝子實體懸浮液,其 中’聚山梨醇酐脂肪酸酯是選自於span 8〇、span85以及 O span 80、span85之混合所組成之群體。 13. 依據申請專利範圍第10項所述之靈芝子實體懸浮液,其 中’該可食性乳化劑是選自於由聚山梨醇酐脂肪酸脂、 脂肪酸甘油脂,以及聚山梨醇酐脂肪酸脂、脂肪酸甘油 脂之混合所組成之群體。 14. 依據申請專利範圍第13項所述之靈芝子實體懸浮液,其 中,聚山梨醇酐脂肪酸酯是選自於span 8〇、span85以及 span 80、Span85之混合所組成之群體。 〇 15· —種奈米/次微米級靈芝子實體懸浮液,是將靈芝子實體 經由機械式研磨後,再經離心所得到之離心上清液,該 奈米/次微米級靈芝子實體懸浮液含有纖維質、幾丁質, 及β-葡聚糖,且靈芝微粒之體積平均粒徑小於2 ^瓜。 16. 依據申請專利範圍第15項所述之奈米/次微米級靈芝子 -實體懸浮液,其中’粒徑小於i _之靈芝微粒佔總靈 - 芝微粒含量的60%以上。 17. 依據申請專利範圍第15或16項所述之奈米/次微米級靈 31 201036621 芝子實體懸浮液,其中 mg/mL 〜1〇〇 mg/mL。 靈芝微粒t濃度範圍介於 18. 依據申請專利範圍第μ項所述之牟 眚辦縣、”“ 項以之Ά次微米級靈芝子 實體懸*液’其中,靈芝微粒之體積平均粒徑小 nm ’且靈芝微粒之粒徑小於1 。 19. 依據申請專利範圍第18項所述 杳抽辟…、A 不、水/次微米級靈芝子 實體懸汗液,其中,5〇%以上的 100 nm〇 靈之微粒的粒徑小於 20.依據申請專利範圍第 實體懸浮液,其中, 〜20 mg/ mL。 19項所述之奈米 靈芝微粒之濃度範 /次微米級靈芝子 圍介於3 mg/mL 19項所述之奈米/次 幾丁質濃度大於(M 21_依據申請專利範圍第Η、μ、18、 微米級靈芝子實體懸浮液,其中, mg/mL。 32201036621 VII. Patent application scope: L A suspension of Ganoderma lucidum fruit body, which starts to grasp π. The body of Maling is served by mechanical grinding and contains the quality of chitosan particles, chitin, and β_” sugar diameter is less than 丨. _. And the volume average particle of the ganoderma lucidum particle ^ according to the patent scope of the first item of the Ganoderma lucidum fruit body suspension, its wide, to, 1 μΐΏ of Ganoderma lucidum particles accounted for 1% of the total mass of Ganoderma lucidum 3. In the second patent range, the chitin content is higher than that of the suspension of Ganoderma lucidum fruit body described in 项. 4. mg/mL. 5. 6. According to the scope of patent application No. 3, the fiber content is higher than 〇. According to the scope of patent application No. 4, the glucan content is higher than the liquid in accordance with the scope of the patent application, and also includes a suspension of Ganoderma lucidum fruit body, which is 1 mg/mL. The edible liquid of the Ganoderma lucidum fruit body suspension, which is 机械.〇1 mg/mL, 2 or 5 of the above-mentioned suspension bodies of the Ganoderma lucidum fruit body, is mechanically ground. 7. According to the scope of the patent application, the edible property Emulsifier is the child of the spirit (4) a floating liquid, the edible emulsifier content being from a nonionic surfactant, and 8. 0.1 to 25% by weight of the sub-entity of the seventh embodiment of the patent application. wherein the edible emulsifier is ^The fruiting body suspension of the spirit of 9. According to f, please patent the range 帛8 ^ value" in 1~18. Among them, the edible emulsifier has a suspension value of 1 to 1 灵. 30 201036621 10. The suspension of Ganoderma lucidum fruit body according to claim 9 of the patent application, wherein the edible emulsifier has an HLB value of 1 to 5. 11. The suspension of Ganoderma lucidum fruit body according to claim 10, wherein the edible emulsifier is selected from the group consisting of vitamin fat, polysorbate fatty acid fat, fatty acid glycerolipid, and borrowing and glycolipid a group consisting of a mixture of polysorbate fatty acid fat and fatty acid glyceride. 12. The suspension of Ganoderma lucidum fruit body according to the scope of claim 5, wherein the polysorbate fatty acid ester is a group selected from the group consisting of span 8〇, span85, and O span 80, span85. 13. The suspension of Ganoderma lucidum fruit body according to claim 10, wherein the edible emulsifier is selected from the group consisting of polysorbate fatty acid fat, fatty acid glyceride, and polysorbate fatty acid fat, fatty acid a group of glycerides mixed. 14. The suspension of Ganoderma lucidum fruit body according to claim 13, wherein the polysorbate fatty acid ester is selected from the group consisting of span 8 〇, span 85, and span 80 and Span 85. 〇15·—A nano/sub-micron-sized suspension of Ganoderma lucidum fruit body, which is a centrifugal supernatant obtained by mechanically grinding the Ganoderma lucidum fruit body and then centrifuging, and the nano/sub-micron Ganoderma lucidum fruit body suspension is suspended. The liquid contains cellulosic, chitin, and β-glucan, and the volume average particle diameter of the ganoderma lucidum particles is less than 2 μ. 16. The nano/sub-micron ganoderma lucidum-solid suspension according to claim 15 wherein the ganoderma lucidum particles having a particle size smaller than i _ occupies more than 60% of the total lings-chicken granule content. 17. The nano/submicron spirit 31 201036621 medicinal suspension according to claim 15 or 16 of the patent application, wherein mg/mL 〜1〇〇 mg/mL. The concentration range of Ganoderma lucidum microparticles is in the range of 18. According to the scope of the patent application, the county is located in the county, "the item is the sub-micron-sized ganoderma lucidum fruit body suspension liquid", wherein the volume average particle size of the ganoderma lucidum particles is small. Nm 'and the size of the Ganoderma lucidum particles is less than 1. 19. According to the scope of the patent application, item 18, extracting, A, water/sub-micron ganoderma lucidum fruit body suspension, wherein more than 5% of the 100 nm 〇 之 particles have a particle size of less than 20. Apply for a patented range of physical suspensions, where, ~20 mg/mL. The concentration of nano-Ganoderma lucidum microparticles in the 19th sub-micron range of Ganoderma lucidum is between 3 mg/mL and the concentration of nano/chitin in 19 items is greater than (M 21_ according to the scope of the patent application, μ, 18, micron-sized suspension of Ganoderma lucidum fruit body, of which, mg/mL.
TW98111670A 2009-04-08 2009-04-08 Suspension liquid of Ganoderma lucidum fruiting bodies and nano/submicron scale suspension liquid of Ganoderma lucidum fruiting bodies TW201036621A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW98111670A TW201036621A (en) 2009-04-08 2009-04-08 Suspension liquid of Ganoderma lucidum fruiting bodies and nano/submicron scale suspension liquid of Ganoderma lucidum fruiting bodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW98111670A TW201036621A (en) 2009-04-08 2009-04-08 Suspension liquid of Ganoderma lucidum fruiting bodies and nano/submicron scale suspension liquid of Ganoderma lucidum fruiting bodies

Publications (2)

Publication Number Publication Date
TW201036621A true TW201036621A (en) 2010-10-16
TWI377065B TWI377065B (en) 2012-11-21

Family

ID=44856331

Family Applications (1)

Application Number Title Priority Date Filing Date
TW98111670A TW201036621A (en) 2009-04-08 2009-04-08 Suspension liquid of Ganoderma lucidum fruiting bodies and nano/submicron scale suspension liquid of Ganoderma lucidum fruiting bodies

Country Status (1)

Country Link
TW (1) TW201036621A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120135127A1 (en) * 2010-11-29 2012-05-31 Sheng Chun Tang Pharmaceutical Industrial Co., Ltd. Dispersion having particles of ganoderma lucidum

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120135127A1 (en) * 2010-11-29 2012-05-31 Sheng Chun Tang Pharmaceutical Industrial Co., Ltd. Dispersion having particles of ganoderma lucidum

Also Published As

Publication number Publication date
TWI377065B (en) 2012-11-21

Similar Documents

Publication Publication Date Title
CN110506930B (en) Starch-based high-stability Pickering emulsion and preparation method thereof
CN110051006B (en) zein/Arabic gum composite nano-particles and preparation method thereof
WO2011096122A1 (en) Method for manufacturing aloe powder
KR100951706B1 (en) Nanoemulsion, nanoparticle containing resveratrol and method of production thereof
WO2022073439A1 (en) Nano-selenium pickering emulsion, preparation method therefor, and applications thereof
TW201036621A (en) Suspension liquid of Ganoderma lucidum fruiting bodies and nano/submicron scale suspension liquid of Ganoderma lucidum fruiting bodies
US20230416302A1 (en) Hemp Seed Protein Pickering Particles as well as Preparation Method and Application Thereof
CN103892256B (en) A kind of preparation method of lucid ganoderma solid beverage
CN101897430B (en) Ganoderma lucidum fruit body suspension and nano/sub-micron grade ganoderma lucidum fruit body suspension
Jia et al. Storage stability and in-vitro release behavior of microcapsules incorporating fish oil by spray drying
JP6018845B2 (en) Method for producing capsule containing ultrafine powder
Chan et al. Emulsion formulation optimization and characterization of spray-dried κ-carrageenan microparticles for the encapsulation of CoQ10
US20090092727A1 (en) Water-dispersible phytosterol-surfactant conglomerate particles
US20120135127A1 (en) Dispersion having particles of ganoderma lucidum
CN113875978B (en) A high internal phase Pickering emulsion prepared from camellia oil and tea cake extract
WO2018153614A1 (en) Treatment of bran from the seeds of black mustard or brown indian mustard and use of the treated bran in food products
CN111481503B (en) Vitamin D3-loaded nano calcium carbonate pickering emulsion and preparation method and application thereof
TWI673012B (en) Micron fish oil composition, and preparation process and uses thereof
CN111642573A (en) Preparation method of high-oil whey powder
JP2021193956A (en) Acetaldehyde metabolism promoter
JP2001029052A (en) Dolomite particle-dispersed drink
Bo et al. Immunoregulatory effects on RAW264. 7 cells and subacute oral toxicity of ultra-large pore mesoporous silica nanoparticles loading Lycium barbarum polysaccharides
CN115057899B (en) Method for extracting anthocyanin from mulberry wine residues
Rad et al. Influence of polymeric complexes on the stability and releasing behavior of phenol-loaded nano-emulsions: Modeling and optimization
Zhu et al. Physical and Antioxidant Properties of Superfine Powders of Golden Imperial Chrysanthemum.